GLP-1 Agonist Medications and Cardiovascular Risk Reduction

This chapter explores the benefits of GLP-1 agonist medications in reducing cardiovascular risk, including weight loss, improved lipid levels, and blood pressure. It discusses the results of various trials that show a decrease in major cardiovascular events, such as heart attacks and strokes, when using these medications. The chapter also mentions the importance of prescribing GLP-1 agonists to individuals at higher risk for cardio metabolic diseases.